Marina Cihova
Overview
Explore the profile of Marina Cihova including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
345
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Trnkova L, Buocikova V, Mego M, Cumova A, Burikova M, Bohac M, et al.
Biomed Pharmacother
. 2024 Apr;
174:116559.
PMID: 38603889
Breast cancer comprises a substantial proportion of cancer diagnoses in women and is a primary cause of cancer-related mortality. While hormone-responsive cases generally have a favorable prognosis, the aggressive nature...
2.
Plava J, cehakova M, Kuniakova M, Trnkova L, Cihova M, Bohac M, et al.
Exp Biol Med (Maywood)
. 2023 Sep;
248(15):1347-1358.
PMID: 37750028
Recent advances in the three-dimensional (3D) cancer models give rise to a plethora of new possibilities in the development of anti-cancer drug therapies and bring us closer to personalized medicine....
3.
Urbanova M, Cihova M, Buocikova V, Slopovsky J, Dubovan P, Pindak D, et al.
Biomed Pharmacother
. 2023 Jul;
165:115179.
PMID: 37481927
Pancreatic ductal adenocarcinoma (PDAC) is among the deadliest cancers worldwide, primarily due to its robust desmoplastic stroma and immunosuppressive tumor microenvironment (TME), which facilitate tumor progression and metastasis. In addition,...
4.
Frutos Diaz-Alejo J, April-Monn S, Cihova M, Buocikova V, Lopez J, Urbanova M, et al.
J Vis Exp
. 2023 Jun;
(195).
PMID: 37306424
Tumor organoids are three-dimensional (3D) ex vivo tumor models that recapitulate the biological key features of the original primary tumor tissues. Patient-derived tumor organoids have been used in translational cancer...
5.
Smolkova B, Kataki A, Earl J, Ruz-Caracuel I, Cihova M, Urbanova M, et al.
Crit Rev Oncol Hematol
. 2022 Nov;
180:103865.
PMID: 36334880
Pancreatic neuroendocrine neoplasms (pNENs) are rare cancers with broad challenges for their management. The main clinical obstacles are the high rate of patients diagnosed at advanced stages, lack of prognostic...
6.
Buocikova V, Longhin E, Pilalis E, Mastrokalou C, Miklikova S, Cihova M, et al.
Biomed Pharmacother
. 2022 Jan;
147:112662.
PMID: 35091237
Acquired drug resistance and metastasis in breast cancer (BC) are coupled with epigenetic deregulation of gene expression. Epigenetic drugs, aiming to reverse these aberrant transcriptional patterns and sensitize cancer cells...
7.
Plava J, Burikova M, Cihova M, Trnkova L, Smolkova B, Babal P, et al.
J Exp Clin Cancer Res
. 2021 Sep;
40(1):302.
PMID: 34579743
Background: Chemotherapy remains a standard treatment option for breast cancer despite its toxic effects to normal tissues. However, the long-lasting effects of chemotherapy on non-malignant cells may influence tumor cell...
8.
Miklikova S, Trnkova L, Plava J, Bohac M, Kuniakova M, Cihova M
Cancers (Basel)
. 2021 Feb;
13(3).
PMID: 33540843
Taking into account the factors of high incidence rate, prevalence and mortality, breast cancer represents a crucial social and economic burden. Most cases of breast cancer develop as a consequence...
9.
Cierna Z, Smolkova B, Cholujova D, Gronesova P, Miklikova S, Cihova M, et al.
Sci Rep
. 2021 Jan;
11(1):1294.
PMID: 33446741
Programmed death ligand 1 (PD-L1) overexpression has been associated with poor clinical outcomes in several human cancers whose increased malignant behaviour might be related to PD-L1 mediated systemic immunological tolerance....
10.
Smolkova B, Cierna Z, Kalavska K, Miklikova S, Plava J, Minarik G, et al.
Int J Mol Sci
. 2020 Dec;
21(24).
PMID: 33322711
Circulating tumor cells (CTCs) and the immune infiltration of tumors are closely related to clinical outcomes. This study aimed to verify the influence of stromal lymphocyte infiltration and the immune...